Every earnings call for DCW — management tone, guidance, KPIs and promise tracking, quarter by quarter.
DCW · 6 transcripts · Chemicals · latest Q4 FY26Revenue ₹609 cr (+13% YoY); EBITDA (incl. other income) ₹70 cr (+14% YoY); PAT ₹18 cr (+60% YoY). Full year FY26 EBITDA grew by approximately 11% year-on-year to Rs.240 crores.
Read full transcript & analysisRevenue (Q3 FY26) ₹520 cr (+10% YoY); EBITDA (Q3 FY26) ₹50 cr (−19% YoY); PBT (Q3 FY26) ₹8 cr. Revenue of ₹520 crores, up 9.6% YoY.
Read full transcript & analysisRevenue ₹539 cr (+10% YoY); EBITDA ₹63 cr (+51% YoY); EBITDA Margin 10.78%. Revenue for Q2 FY26 grew 10.22% YoY to ₹539 crores.
Read full transcript & analysisRevenue ₹475 cr (−5% YoY); EBITDA ₹58 cr (+12% YoY); EBITDA Margin 11.3%. PAT grew 70% YoY to ₹11.4 crores.
Read full transcript & analysisRevenue ₹538 cr (−13% YoY); EBITDA ₹62 cr (−10% YoY); EBITDA Margin 11.0%. FY25 Revenue grew 7% YoY to ₹2,000 crores.
Read full transcript & analysisRevenue ₹474 cr (+19% YoY); EBITDA ₹62 cr (+164% YoY); EBITDA Margin 13%. Revenue from operations grew by 19.09% YoY to ₹474 crores.
Read full transcript & analysis